New frontiers of retinal therapeutic intervention: a critical analysis of novel approaches.

Nanegrungsunk, Onnisa; Au, Adrian; Sarraf, David; Sadda, Srinivas R

Nanegrungsunk, Onnisa; Au, Adrian; Sarraf, David; Sadda, Srinivas R.

Affiliation

Nanegrungsunk O; Doheny Eye Institute, Pasadena, CA, USA.
Au A; Department of Ophthalmology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA.
Sarraf D; Retina Division, Department of Ophthalmology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Sadda SR; Stein Eye Institute, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA.

Ann Med ; 54(1): 1067-1080, 2022 12.

Article in En | MEDLINE | ID: mdl-35467460

Subject(s)

Quality of Life; Retinal Diseases; Genetic Therapy; Humans; Retina; Retinal Diseases/drug therapy; United States

Key words

Advanced therapy; anti-vascular endothelial growth factor (anti-VEGF); artificial vision; complement cascade targeted therapy; dual-target therapy; gene therapy; optogenetics gene therapy; port delivery system; retinal prosthesis; stem cell therapy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Retinal Diseases Aspects: Patient_preference Limits: Humans Country/Region as subject: America do norte Language: En Journal: Ann Med Journal subject: MEDICINA Year: 2022 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google